Filter
157
Filtered Results: 157
Text search:
EMA
European
Medicines
Agency
Featured
Recommendations
19
New Publications
34
Language
Document type
No document type
56
Guidelines
42
Studies & Reports
26
Fact sheets
21
Manuals
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Brochures
1
Countries / Regions
Germany
7
Western and Central Europe
5
Colombia
3
West and Central Africa
3
Africa
2
East and Southern Africa
2
Eastern Europe
2
Brazil
2
Tajikistan
1
Nepal
1
Thailand
1
Kenya
1
Ukraine
1
Sierra Leone
1
Chile
1
Peru
1
Philippines
1
Guinea
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
Paraguay
1
Denmark
1
Spain
1
Argentina
1
Bangladesh
1
Uganda
1
Russia
1
Ethiopia
1
Zambia
1
Indonesia
1
Liberia
1
Ecuador
1
India
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
32
Countries
28
Pharmacy & Technologies
6
Women & Child Health
5
Key Resources
2
Capacity Building
1
Public Health
1
Toolboxes
COVID-19
39
AMR
28
HIV
10
TB
9
Ebola & Marburg
9
Pharmacy
8
Rapid Response
7
NTDs
5
Mental Health
4
Planetary Health
4
Refugee
3
Zika
2
Natural Hazards
1
Disability
1
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
Front. Trop. Dis. , 09 May 2023 Sec. Neglected Tropical Diseases Volume 4 - 2023 | https://doi.org/10.3389/fitd.2023.1087003
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
16-17 march 2015, Geneva, Switzerland
Meeting report
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Principles and Target Product Criteria. Roadmap January 12, 2015
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
16.7.2021
Guidelines for the care of children and adolescents diagnosed with COVID - 19.
